Literature DB >> 23086612

An unexpected mortality following cardiac surgery: a post-mortem diagnosis of cardiac amyloidosis.

Gerard J Fitzmaurice1, Victoria Wishart, Alastair N J Graham.   

Abstract

Amyloidosis is a rare systemic disease that is notoriously difficult to diagnose early. Cardiac involvement is associated with a poor prognosis. We present the case of a 72-year-old gentleman who underwent elective coronary artery bypass grafting and mitral valve repair. While initially making a good post-operative recovery, a sudden deterioration on post-operative day 3 led to an unexpected mortality. Post-mortem examination demonstrated previously undiagnosed severe systemic amyloidosis, which particularly affected his heart, due to underlying multiple myeloma. It is important to emphasise that due to the absence of the typical findings on routine pre-operative investigations suggestive of cardiac amyloidosis in this patient, cardiac surgeons should be aware that symptoms inconsistent with angiography findings should prompt consideration of amyloidosis. Diagnostic tools including cardiac MRI and ultimately endomyocardial biopsy could then facilitate earlier recognition of this enigmatic disease process.

Entities:  

Mesh:

Year:  2012        PMID: 23086612     DOI: 10.1007/s11748-012-0164-6

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  12 in total

1.  Fatal perioperative myocardial infarction in four patients with cardiac amyloidosis.

Authors:  N Kotani; H Hashimoto; M Muraoka; S Kabara; H Okawa; A Matsuki
Journal:  Anesthesiology       Date:  2000-03       Impact factor: 7.892

2.  Amyloid of heart and lungs in a patient with low output syndrome after coronary artery bypass grafting.

Authors:  Parwis Massoudy; Andras K Szabo; Olaf Dirsch; Heiner Wienecke; Henry J C M van de Wal; Heinz G Jakob
Journal:  Herz       Date:  2003-08       Impact factor: 1.443

3.  How to diagnose cardiac amyloidosis early: impact of ECG, tissue Doppler echocardiography, and myocardial biopsy.

Authors:  Cornelia Piper; Thomas Butz; Martin Farr; Lothar Faber; Olaf Oldenburg; Dieter Horstkotte
Journal:  Amyloid       Date:  2010-03       Impact factor: 7.141

Review 4.  Cardiac amyloidosis: an approach to diagnosis and management.

Authors:  Omaira Halwani; Diego H Delgado
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-07

5.  2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Kanu Chatterjee; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce W Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise
Journal:  Circulation       Date:  2008-09-26       Impact factor: 29.690

6.  Angina with a normal coronary angiogram caused by amyloidosis.

Authors:  D C Whitaker; M F Tungekar; J E Dussek
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

7.  Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis.

Authors:  Arnt V Kristen; Falk-Udo Sack; Stefan O Schonland; Ute Hegenbart; Burkhard M Helmke; Achim Koch; Philipp A Schnabel; Christoph Röcken; Stefan Hardt; Andrew Remppis; Hartmut Goldschmidt; Matthias Karck; Anthony D Ho; Hugo A Katus; Thomas J Dengler
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534

8.  Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.

Authors:  Falk-Udo Sack; Arnt Kristen; Hartmut Goldschmidt; Philipp A Schnabel; Thomas Dengler; Achim Koch; Matthias Karck
Journal:  Eur J Cardiothorac Surg       Date:  2007-12-21       Impact factor: 4.191

9.  [Cardiac amyloidosis--cardiovascular magnetic resonance imaging as a valuable diagnostic tool].

Authors:  G Braun; U Sechtem; H Mahrholdt
Journal:  Dtsch Med Wochenschr       Date:  2009-04-01       Impact factor: 0.628

10.  Unsuspected amyloidosis and cardiac arrest following mitral valve replacement.

Authors:  J G Schwartz; J J Ghidoni
Journal:  Int J Cardiol       Date:  1985-12       Impact factor: 4.164

View more
  4 in total

1.  Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.

Authors:  Lauren Gray Gilstrap; Emily Niehaus; Rajeev Malhotra; Van-Khue Ton; James Watts; David C Seldin; Joren C Madsen; Marc J Semigran
Journal:  J Heart Lung Transplant       Date:  2013-11-05       Impact factor: 10.247

2.  Postmortem MR quantification of the heart for characterization and differentiation of ischaemic myocardial lesions.

Authors:  Wolf-Dieter Zech; Nicole Schwendener; Anders Persson; Marcel J Warntjes; Christian Jackowski
Journal:  Eur Radiol       Date:  2015-01-16       Impact factor: 5.315

3.  Temperature dependence of postmortem MR quantification for soft tissue discrimination.

Authors:  Wolf-Dieter Zech; Nicole Schwendener; Anders Persson; Marcel J Warntjes; Christian Jackowski
Journal:  Eur Radiol       Date:  2015-02-01       Impact factor: 5.315

4.  Role of imaging for diagnosis and management of aortic valve papillary fibroelastoma and cardiac amyloid light chain amyloidosis: a case report.

Authors:  Ivan Dimov; Nathalie Meuleman; Didier de Cannière; Philippe Unger
Journal:  Eur Heart J Case Rep       Date:  2021-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.